Cargando…

Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old

BACKGROUND: Given the potential for older patients to experience exaggerated toxicity and symptoms, this study was performed to characterize patient reported outcomes in older patients following definitive radiation therapy (RT) for oropharyngeal cancer (OPC). METHODS: Cancer-free head and neck canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Eraj, Salman A., Jomaa, Mona K., Rock, Crosby D., Mohamed, Abdallah S. R., Smith, Blaine D., Smith, Joshua B., Browne, Theodora, Cooksey, Luke C., Williams, Bowman, Temple, Brandi, Preston, Kathryn E., Aymar, Jeremy M., Gross, Neil D., Weber, Randal S., Hessel, Amy C., Ferrarotto, Renata, Phan, Jack, Sturgis, Erich M., Hanna, Ehab Y., Frank, Steven J., Morrison, William H., Goepfert, Ryan P., Lai, Stephen Y., Rosenthal, David I., Mendoza, Tito R., Cleeland, Charles S., Hutcheson, Kate A., Fuller, Clifton D., Garden, Adam S., Gunn, G. Brandon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591495/
https://www.ncbi.nlm.nih.gov/pubmed/28888224
http://dx.doi.org/10.1186/s13014-017-0878-9
_version_ 1783262724090757120
author Eraj, Salman A.
Jomaa, Mona K.
Rock, Crosby D.
Mohamed, Abdallah S. R.
Smith, Blaine D.
Smith, Joshua B.
Browne, Theodora
Cooksey, Luke C.
Williams, Bowman
Temple, Brandi
Preston, Kathryn E.
Aymar, Jeremy M.
Gross, Neil D.
Weber, Randal S.
Hessel, Amy C.
Ferrarotto, Renata
Phan, Jack
Sturgis, Erich M.
Hanna, Ehab Y.
Frank, Steven J.
Morrison, William H.
Goepfert, Ryan P.
Lai, Stephen Y.
Rosenthal, David I.
Mendoza, Tito R.
Cleeland, Charles S.
Hutcheson, Kate A.
Fuller, Clifton D.
Garden, Adam S.
Gunn, G. Brandon
author_facet Eraj, Salman A.
Jomaa, Mona K.
Rock, Crosby D.
Mohamed, Abdallah S. R.
Smith, Blaine D.
Smith, Joshua B.
Browne, Theodora
Cooksey, Luke C.
Williams, Bowman
Temple, Brandi
Preston, Kathryn E.
Aymar, Jeremy M.
Gross, Neil D.
Weber, Randal S.
Hessel, Amy C.
Ferrarotto, Renata
Phan, Jack
Sturgis, Erich M.
Hanna, Ehab Y.
Frank, Steven J.
Morrison, William H.
Goepfert, Ryan P.
Lai, Stephen Y.
Rosenthal, David I.
Mendoza, Tito R.
Cleeland, Charles S.
Hutcheson, Kate A.
Fuller, Clifton D.
Garden, Adam S.
Gunn, G. Brandon
collection PubMed
description BACKGROUND: Given the potential for older patients to experience exaggerated toxicity and symptoms, this study was performed to characterize patient reported outcomes in older patients following definitive radiation therapy (RT) for oropharyngeal cancer (OPC). METHODS: Cancer-free head and neck cancer survivors (>6 months since treatment completion) were eligible for participation in a questionnaire-based study. Participants completed the MD Anderson Symptom Inventory-Head and Neck module (MDASI-HN). Those patients ≥65 years old at treatment for OPC with definitive RT were included. Individual and overall symptom severity and clinical variables were analyzed. RESULTS: Of the 79 participants analyzed, 82% were male, 95% white, 41% T3/4 disease, 39% RT alone, 27% induction chemotherapy, 52% concurrent, and 18% both, and 96% IMRT. Median age at RT was 71 yrs. (range: 65–85); median time from RT to MDASI-HN was 46 mos. (2/3 > 24 mos.). The top 5 MDASI-HN items rated most severe in terms of mean (±SD) ratings (0–10 scale) were dry mouth (3.48 ± 2.95), taste (2.81 ± 3.29), swallowing (2.59 ± 2.96), mucus in mouth/throat (2.04 ± 2.68), and choking (1.30 ± 2.38) reported at moderate-severe levels (≥5) by 35, 29, 29, 18, and 13%, respectively. Thirty-nine % reported none (0) or no more than mild (1–4) symptoms across all 22 MDASI-HN symptoms items, and 38% had at least one item rated as severe (≥7). Hierarchical cluster analysis resulted in 3 patient groups: 1) ~65% with ranging from none to moderate symptom burden, 2) ~35% with moderate-severe ratings for a subset of classically RT-related symptoms (e.g. dry mouth, mucus, swallowing) and 3) 2 pts. with severe ratings of most items. CONCLUSIONS: The overall long-term symptom burden seen in this older OPC cohort treated with modern standard therapy was largely favorable, yet a higher symptom group (~35%) with a distinct pattern of mostly local and classically RT-related symptoms was identified. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article doi: (10.1186/s13014-017-0878-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5591495
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55914952017-09-13 Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old Eraj, Salman A. Jomaa, Mona K. Rock, Crosby D. Mohamed, Abdallah S. R. Smith, Blaine D. Smith, Joshua B. Browne, Theodora Cooksey, Luke C. Williams, Bowman Temple, Brandi Preston, Kathryn E. Aymar, Jeremy M. Gross, Neil D. Weber, Randal S. Hessel, Amy C. Ferrarotto, Renata Phan, Jack Sturgis, Erich M. Hanna, Ehab Y. Frank, Steven J. Morrison, William H. Goepfert, Ryan P. Lai, Stephen Y. Rosenthal, David I. Mendoza, Tito R. Cleeland, Charles S. Hutcheson, Kate A. Fuller, Clifton D. Garden, Adam S. Gunn, G. Brandon Radiat Oncol Research BACKGROUND: Given the potential for older patients to experience exaggerated toxicity and symptoms, this study was performed to characterize patient reported outcomes in older patients following definitive radiation therapy (RT) for oropharyngeal cancer (OPC). METHODS: Cancer-free head and neck cancer survivors (>6 months since treatment completion) were eligible for participation in a questionnaire-based study. Participants completed the MD Anderson Symptom Inventory-Head and Neck module (MDASI-HN). Those patients ≥65 years old at treatment for OPC with definitive RT were included. Individual and overall symptom severity and clinical variables were analyzed. RESULTS: Of the 79 participants analyzed, 82% were male, 95% white, 41% T3/4 disease, 39% RT alone, 27% induction chemotherapy, 52% concurrent, and 18% both, and 96% IMRT. Median age at RT was 71 yrs. (range: 65–85); median time from RT to MDASI-HN was 46 mos. (2/3 > 24 mos.). The top 5 MDASI-HN items rated most severe in terms of mean (±SD) ratings (0–10 scale) were dry mouth (3.48 ± 2.95), taste (2.81 ± 3.29), swallowing (2.59 ± 2.96), mucus in mouth/throat (2.04 ± 2.68), and choking (1.30 ± 2.38) reported at moderate-severe levels (≥5) by 35, 29, 29, 18, and 13%, respectively. Thirty-nine % reported none (0) or no more than mild (1–4) symptoms across all 22 MDASI-HN symptoms items, and 38% had at least one item rated as severe (≥7). Hierarchical cluster analysis resulted in 3 patient groups: 1) ~65% with ranging from none to moderate symptom burden, 2) ~35% with moderate-severe ratings for a subset of classically RT-related symptoms (e.g. dry mouth, mucus, swallowing) and 3) 2 pts. with severe ratings of most items. CONCLUSIONS: The overall long-term symptom burden seen in this older OPC cohort treated with modern standard therapy was largely favorable, yet a higher symptom group (~35%) with a distinct pattern of mostly local and classically RT-related symptoms was identified. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article doi: (10.1186/s13014-017-0878-9) contains supplementary material, which is available to authorized users. BioMed Central 2017-09-09 /pmc/articles/PMC5591495/ /pubmed/28888224 http://dx.doi.org/10.1186/s13014-017-0878-9 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Eraj, Salman A.
Jomaa, Mona K.
Rock, Crosby D.
Mohamed, Abdallah S. R.
Smith, Blaine D.
Smith, Joshua B.
Browne, Theodora
Cooksey, Luke C.
Williams, Bowman
Temple, Brandi
Preston, Kathryn E.
Aymar, Jeremy M.
Gross, Neil D.
Weber, Randal S.
Hessel, Amy C.
Ferrarotto, Renata
Phan, Jack
Sturgis, Erich M.
Hanna, Ehab Y.
Frank, Steven J.
Morrison, William H.
Goepfert, Ryan P.
Lai, Stephen Y.
Rosenthal, David I.
Mendoza, Tito R.
Cleeland, Charles S.
Hutcheson, Kate A.
Fuller, Clifton D.
Garden, Adam S.
Gunn, G. Brandon
Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old
title Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old
title_full Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old
title_fullStr Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old
title_full_unstemmed Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old
title_short Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old
title_sort long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591495/
https://www.ncbi.nlm.nih.gov/pubmed/28888224
http://dx.doi.org/10.1186/s13014-017-0878-9
work_keys_str_mv AT longtermpatientreportedoutcomesfollowingradiationtherapyfororopharyngealcancercrosssectionalassessmentofaprospectivesymptomsurveyinpatients65yearsold
AT erajsalmana longtermpatientreportedoutcomesfollowingradiationtherapyfororopharyngealcancercrosssectionalassessmentofaprospectivesymptomsurveyinpatients65yearsold
AT jomaamonak longtermpatientreportedoutcomesfollowingradiationtherapyfororopharyngealcancercrosssectionalassessmentofaprospectivesymptomsurveyinpatients65yearsold
AT rockcrosbyd longtermpatientreportedoutcomesfollowingradiationtherapyfororopharyngealcancercrosssectionalassessmentofaprospectivesymptomsurveyinpatients65yearsold
AT mohamedabdallahsr longtermpatientreportedoutcomesfollowingradiationtherapyfororopharyngealcancercrosssectionalassessmentofaprospectivesymptomsurveyinpatients65yearsold
AT smithblained longtermpatientreportedoutcomesfollowingradiationtherapyfororopharyngealcancercrosssectionalassessmentofaprospectivesymptomsurveyinpatients65yearsold
AT smithjoshuab longtermpatientreportedoutcomesfollowingradiationtherapyfororopharyngealcancercrosssectionalassessmentofaprospectivesymptomsurveyinpatients65yearsold
AT brownetheodora longtermpatientreportedoutcomesfollowingradiationtherapyfororopharyngealcancercrosssectionalassessmentofaprospectivesymptomsurveyinpatients65yearsold
AT cookseylukec longtermpatientreportedoutcomesfollowingradiationtherapyfororopharyngealcancercrosssectionalassessmentofaprospectivesymptomsurveyinpatients65yearsold
AT williamsbowman longtermpatientreportedoutcomesfollowingradiationtherapyfororopharyngealcancercrosssectionalassessmentofaprospectivesymptomsurveyinpatients65yearsold
AT templebrandi longtermpatientreportedoutcomesfollowingradiationtherapyfororopharyngealcancercrosssectionalassessmentofaprospectivesymptomsurveyinpatients65yearsold
AT prestonkathryne longtermpatientreportedoutcomesfollowingradiationtherapyfororopharyngealcancercrosssectionalassessmentofaprospectivesymptomsurveyinpatients65yearsold
AT aymarjeremym longtermpatientreportedoutcomesfollowingradiationtherapyfororopharyngealcancercrosssectionalassessmentofaprospectivesymptomsurveyinpatients65yearsold
AT grossneild longtermpatientreportedoutcomesfollowingradiationtherapyfororopharyngealcancercrosssectionalassessmentofaprospectivesymptomsurveyinpatients65yearsold
AT weberrandals longtermpatientreportedoutcomesfollowingradiationtherapyfororopharyngealcancercrosssectionalassessmentofaprospectivesymptomsurveyinpatients65yearsold
AT hesselamyc longtermpatientreportedoutcomesfollowingradiationtherapyfororopharyngealcancercrosssectionalassessmentofaprospectivesymptomsurveyinpatients65yearsold
AT ferrarottorenata longtermpatientreportedoutcomesfollowingradiationtherapyfororopharyngealcancercrosssectionalassessmentofaprospectivesymptomsurveyinpatients65yearsold
AT phanjack longtermpatientreportedoutcomesfollowingradiationtherapyfororopharyngealcancercrosssectionalassessmentofaprospectivesymptomsurveyinpatients65yearsold
AT sturgiserichm longtermpatientreportedoutcomesfollowingradiationtherapyfororopharyngealcancercrosssectionalassessmentofaprospectivesymptomsurveyinpatients65yearsold
AT hannaehaby longtermpatientreportedoutcomesfollowingradiationtherapyfororopharyngealcancercrosssectionalassessmentofaprospectivesymptomsurveyinpatients65yearsold
AT frankstevenj longtermpatientreportedoutcomesfollowingradiationtherapyfororopharyngealcancercrosssectionalassessmentofaprospectivesymptomsurveyinpatients65yearsold
AT morrisonwilliamh longtermpatientreportedoutcomesfollowingradiationtherapyfororopharyngealcancercrosssectionalassessmentofaprospectivesymptomsurveyinpatients65yearsold
AT goepfertryanp longtermpatientreportedoutcomesfollowingradiationtherapyfororopharyngealcancercrosssectionalassessmentofaprospectivesymptomsurveyinpatients65yearsold
AT laistepheny longtermpatientreportedoutcomesfollowingradiationtherapyfororopharyngealcancercrosssectionalassessmentofaprospectivesymptomsurveyinpatients65yearsold
AT rosenthaldavidi longtermpatientreportedoutcomesfollowingradiationtherapyfororopharyngealcancercrosssectionalassessmentofaprospectivesymptomsurveyinpatients65yearsold
AT mendozatitor longtermpatientreportedoutcomesfollowingradiationtherapyfororopharyngealcancercrosssectionalassessmentofaprospectivesymptomsurveyinpatients65yearsold
AT cleelandcharless longtermpatientreportedoutcomesfollowingradiationtherapyfororopharyngealcancercrosssectionalassessmentofaprospectivesymptomsurveyinpatients65yearsold
AT hutchesonkatea longtermpatientreportedoutcomesfollowingradiationtherapyfororopharyngealcancercrosssectionalassessmentofaprospectivesymptomsurveyinpatients65yearsold
AT fullercliftond longtermpatientreportedoutcomesfollowingradiationtherapyfororopharyngealcancercrosssectionalassessmentofaprospectivesymptomsurveyinpatients65yearsold
AT gardenadams longtermpatientreportedoutcomesfollowingradiationtherapyfororopharyngealcancercrosssectionalassessmentofaprospectivesymptomsurveyinpatients65yearsold
AT gunngbrandon longtermpatientreportedoutcomesfollowingradiationtherapyfororopharyngealcancercrosssectionalassessmentofaprospectivesymptomsurveyinpatients65yearsold